Mylan appoints Daniel M. Gallagher as chief legal officer
Staff Writer |
Hertfordshire, United Kingdom - March 29, 2017, Hertfordshire, United Kingdom - Mylan, a pharmaceutical company, announced the appointment of Daniel M. Gallagher as chief legal officer, effective April 17, 2017.
Article continues below
Mr. Gallagher joins Mylan from Patomak Global Partners, a consulting firm providing strategic advice, compliance consulting, and litigation and regulatory enforcement services, where he was president.
From November 2011 to October 2015, Mr. Gallagher served as a commissioner of the U.S. Securities and Exchange Commission (SEC).
Before being appointed commissioner, Mr. Gallagher served on the staff of the SEC in several capacities, including as counsel to both SEC Commissioner Paul Atkins and Chairman Christopher Cox, working on matters involving the Division of Enforcement and the Division of Trading and Markets.
He served as deputy director and co-acting director of the Division of Trading and Markets from 2008 to 2010, where he was on the front lines of the agency's response to the financial crisis, including representing the Commission in the Lehman Brothers liquidation.
In addition to his tenure in public service, he spent a number of years in the private sector.
Following law school, Mr. Gallagher joined the Washington, D.C. law firm Wilmer Cutler & Pickering, where he advised clients on broker-dealer regulatory issues and represented clients in SEC and SRO enforcement proceedings.
He later returned to Wilmer (now WilmerHale) as a partner following his staff service at the SEC. H also served as senior vice president and general counsel of Fiserv Securities, Inc., where he was responsible for managing all of the firm's legal and regulatory matters.
Mr. Gallagher received his B.A. in English from Georgetown University and his J.D., magna cum laude, from the Catholic University of America, where he was a member of the Law Review. ■